metadata toggle
Contra-indications, warnings, etc
Do not use the product in cases of known hypersensitivity to the active substance or any of the excipients.
The product does not treat juvenile attached sea lice which may be present with the pre-adult and adult stages. These juvenile stages will develop into pre-adults and adults in 10 to 20 days when the population count should show whether a second treatment is necessary. All fish on the site should be simultaneously treated.
Resistance is known to occur where incomplete treatments are carried out. To help prevent resistance occurring ensure the correct dose and duration of treatment is accomplished. Only fully enclosed treatments should be used. Repeated use of the same class of chemotherapeutic agent may result in the development of resistance. In order to reduce the risk of resistance to the product developing, the product should be used as part of a rotational strategy in the medicinal treatment of sea lice.
Where there are concerns of decreasing sensitivity of lice to Azamethiphos based products the maximum treatment time (60 minutes) should be used to achieve optimum efficacy and limit the opportunity for resistance development.
Do not use the product prophylactically. Only use when infestation with mature lice has been diagnosed.
Signs of hyperactivity or distress may be seen if fish are not adequately oxygenated during treatment.
Mortalities of treated fish is uncommonly observed.
The frequency of adverse reactions is defined using the following convention:
-very common (more than 1 in 10 animals treated displaying adverse reaction(s))
-common (more than 1 but less than 10 animals in 100 animals treated)
-uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
-rare (more than 1 but less than 10 animals in 10,000 animals treated)
-very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
The safety of the product with regard to reproduction toxicity has not been assessed. Therefore, only use in maturing brood stock in accordance with the benefit/risk assessment by the responsible veterinarian.